Translational Development Acquisition Corp. Warrants financials
$1.50−1.76%
Close Sep 28, 2026 · split-adjustedRevenue
Net income
Income statement & cash flow
| Quarter | Q2 '26 Jun 30 | Q1 '26 Mar 31 | Q4 '25 Dec 31 | Q3 '25 Sep 30 | Q2 '25 Jun 30 | Q1 '25 Mar 31 | Q3 '21 Sep 30 | Q2 '21 Jun 30 | Q1 '21 Mar 31 | Q4 '20 Dec 31 | Q3 '20 Sep 30 | Q2 '20 Jun 30 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $1.7M | $9.9M | $5.5M | — | — | — |
| Gross profit | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | -$219.4K | $8.8M | $2.5M | — | — | — |
| Gross margin | — | — | — | — | — | — | −12.9% | 89.2% | 46.0% | — | — | — |
| Operating income | -$661.0K | -$281.2K | -$162.3K | -$213.7K | -$221.1K | -$347.4K | -$5.8M | $1.1M | -$2.8M | -$2.6M | -$532.7K | -$334.4K |
| Net income | $947.0K | $1.3M | $1.6M | $1.7M | $1.6M | $1.5M | -$11.6M | -$1.4M | -$5.5M | -$5.2M | -$362.5K | -$279.4K |
| Net margin | — | — | — | — | — | — | −682.0% | −14.4% | −99.9% | — | — | — |
| Diluted EPS | $0.04 | $0.06 | $0.07 | $0.08 | $0.07 | $0.07 | $-4.60 | $-0.60 | $-2.40 | $-2.10 | $-0.30 | $-0.40 |
| EBITDA | -$661.0K | -$281.2K | -$162.3K | -$213.7K | -$221.1K | -$347.4K | -$5.8M | $2.0M | -$2.4M | -$2.6M | -$532.7K | -$334.4K |
| Operating cash flow | -$338.8K | -$305.2K | -$117.4K | -$88.1K | -$171.3K | -$231.6K | -$21.0M | -$442.1K | -$3.9M | $6.3M | -$1.0M | -$440.5K |
| Free cash flow | -$338.8K | -$305.2K | -$117.4K | -$88.1K | -$171.3K | -$231.6K | -$21.3M | -$442.1K | -$3.9M | — | — | — |
| Diluted shares | 21.5M | 21.9M | 21.9M | 21.9M | 21.9M | 21.9M | 2.5M | 2.4M | 2.3M | 2.3M | 1.2M | 0.7M |
Balance sheet
| Period end | Jun 30 | Mar 31 | Dec 31 | Sep 30 | Jun 30 | Mar 31 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $85.9K | $24.6K | $29.8K | $47.1K | $35.3K | $206.6K |
| Short-term investments | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 | $0.00 |
| Total debt | $1.1M | $6.5M | $200.0K | $6.1M | $6.0M | $6.0M |
| Total assets | $157.4M | $183.3M | $181.7M | $180.0M | $178.2M | $176.6M |
| Total liabilities | $7.8M | $6.9M | $6.6M | $6.5M | $6.3M | $6.4M |
| Shareholders' equity | -$7.7M | -$6.8M | -$6.5M | -$6.4M | -$6.2M | -$5.9M |
From SEC filings via Massive. Fiscal periods follow the company's own calendar; free cash flow is operating cash flow minus capital expenditure.
Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology